Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020

Stem cell therapy has been considered a promising strategy in the management of both type I and type II diabetes mellitus (DM) because of its immunomodulatory and regenerative capability to restore the beta cell number and function. Various modalities of cellular therapy like transplantation of panc...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthu, Sathish, Jeyaraman, Madhan, Jeyaraman, Naveen, Rajendran, Ramya Lakshmi, Gangadaran, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615097/
https://www.ncbi.nlm.nih.gov/pubmed/34821725
http://dx.doi.org/10.3390/bioengineering8110159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615097/
https://www.ncbi.nlm.nih.gov/pubmed/34821725
http://dx.doi.org/10.3390/bioengineering8110159

Ejemplares similares